A 16-Year-Old's Confidential Chlamydia Result and a Mother in the Waiting Room
A 16-year-old girl comes to your clinic with her mother, who is in the waiting room. At the start of the visit she says she has a new partner and asks for STI testing, and asks that her mother not be told anything. The urine NAAT returns positive for chlamydia; gonorrhea and HIV are negative. She is covered under her mother's insurance policy and does not know how the explanation of benefits is delivered. She reports one partner and is unsure whether he has told anyone. She says, "If my mom finds out I'm having sex, she'll throw me out." When you walk to the waiting room, her mother asks what the results were and asks for a printout "for the family file."
1. How do you handle the mother's request, legally and ethically?
Read the worked answer
In most states a 16-year-old may consent to her own STI testing and treatment, and those results are confidential. Disclosing them over her objection would violate that protection and would almost certainly end her engagement in care. So the answer to the mother's request is a clear, kind no, not a printout.
Say something like: "I understand you want to know what's going on. I can't share the details of this visit, which is true for all of my adolescent patients, but I'd be glad to help her talk with you." Do not lie and do not imply everything is normal; do not confirm or deny any specific test.
The insurance plan is the real leak. A 16-year-old on her mother's policy may have an explanation of benefits mailed to the policyholder naming the visit and the tests. Before anything is submitted, check billing options: self-pay on a sliding scale, a confidential address of record, or a state minor-consent confidentiality program. Ask her directly whether mail goes to her home and who opens it. Verify the state's minor consent statute and the clinic's confidentiality policy rather than relying on memory.
2. What are your next steps for treatment, partner management, and reporting?
Read the worked answer
Treat today. Doxycycline 100 mg orally twice daily for 7 days is now first-line for chlamydia, including in adolescents. If adherence is genuinely doubtful - and it may be, given her home situation - single-dose azithromycin 1 g is an alternative, though it is somewhat less effective and contributes to resistance. Give the first dose observed in clinic. Also test for gonorrhea, trichomonas, syphilis, HIV, hepatitis B, and pregnancy, and offer contraception.
Partners: she should notify partners from the preceding 60 days. Where state law permits, use expedited partner therapy, providing a prescription or medication for partners without an examination, and document it.
Reporting: chlamydia is a reportable condition in most jurisdictions. Report according to state requirements, which are designed to preserve patient confidentiality.
Retest at 3 months for reinfection regardless of partner treatment; reinfection rather than treatment failure is the usual cause of recurrence.
Prevention: condoms, a contraception plan including emergency contraception, HPV vaccine if incomplete, and hepatitis B status. Frame all of it as services rather than as consequences.
3. She has disclosed a fear of being thrown out of her home. How does that change your assessment and documentation?
Read the worked answer
Safety first. "She'll throw me out" is not hyperbole in an adolescent who has just disclosed sexual activity in a family that may not accept it. Ask directly about fear of being kicked out, physical safety at home, and coercion or a substantially older partner, which may trigger mandated reporting depending on the age gap and state law. Know the local youth housing, drop-in, and crisis resources before she leaves, and give them in writing.
Mental health: screen for depression and for intimate partner violence. A new STI diagnosis in an adolescent is a reasonable trigger for both, and the visit is already confidential.
Make the confidentiality promise operational, not rhetorical. Tell her exactly what will and will not be shared, what would break confidentiality (imminent danger to herself or others, abuse), and how results will reach her - portal, text, or phone. Confirm the phone number is one her mother does not monitor.
Close the loop: a nurse or community health worker call at 72 hours to confirm she received and tolerated the medication, and at 3 months for retesting. Document the confidentiality discussion, the billing choice, and the safety assessment, because the next clinician who sees her will need all three and she may not repeat the story.